Unconfirmed Rumors Circulate that Delcath Systems Inc. (DCTH) will get an FDA fast-track approval for stage 3 liver cancer treatment

February 3, 2011 10:19 AM | 8 seconds read |
Unconfirmed Rumors Circulate that Delcath Systems Inc. (DCTH) will get an FDA fast-track approval for stage 3 liver cancer treatment..Stock would trade to Mid 20s..
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsRumorsM&AHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!